UiPath’s AI Monetization Stalls—Investors Demand Proof to Justify Premium

UiPath delivered a strong quarterly print, but the market's verdict was a decisive "sell." For the fourth quarter, the company reported revenue of $481.1 million, a 3.5% beat against analyst estimates. More impressively, its non-GAAP earnings per share of $0.30 cleared the consensus by 17.8%. The beat was broad, extending to operating income, which also topped expectations.

Yet the stock plunged 10% during early trading on Thursday after the report. This stark disconnect is the classic "sell the news" dynamic. The strong beat was already priced in. The real story for investors was in the guidance and the forward view. While the company's outlook for the next quarter was in line with expectations, the broader trajectory revealed a slower growth path than the market had hoped for.

The expectation gap was sealed by analyst reactions. Just days after the report, BMO Capital reduced its price target for UiPath to $14 from $17, maintaining a Market Perform rating. The firm's rationale was clear: investors will require further proof of ongoing AI monetization to stay loyal. In other words, the company's execution on its AI product line, which is critical for future growth, did not yet provide enough conviction to justify a higher valuation. The earnings beat was the rumor; the guidance reset and the call for more AI proof were the reality the market had not fully priced in.

The Expectation Gap: Whisper Numbers vs. Reality

The market's harsh reaction to UiPath's earnings stems from a classic expectation gap. For years, the stock has been a story of consistent beats. As one social media discussion noted, investors highlighted the company's history of beating EPS and revenue estimates in nearly every quarter since its IPO. This track record set a high bar, turning each quarterly report into a test of whether the company could meet or exceed an elevated "whisper number." The Q4 print, with revenue and EPS both beating estimates, was the expected outcome. The reality that shocked the market was the forward view.

While the company's ARR grew 11% year-over-year to $1.853 billion, the guidance for the coming year implies a deceleration. The fiscal 2027 ARR growth estimate of roughly 10.8% projects net new ARR of $200 million vs $187 million in the previous fiscal year. This is a clear slowdown from the prior year's net new ARR growth. In a market hungry for acceleration, this guidance reset signaled a more tempered growth path than many had priced in.

The core of the skepticism lies in the AI narrative. UiPath has heavily promoted its Maestro platform and agentic AI as the next growth engine. The company points to nearly $200 million in AI Product ARR and strong engagement from high-value customers. Yet, as BMO Capital's analyst noted, investors will require further proof of ongoing AI monetization to stay loyal. The disconnect is stark: the company is executing on AI adoption in its largest accounts, but the market needs to see that translate into broader, predictable revenue growth that justifies a premium valuation. The stock's plunge reflects a market that has priced in a faster AI monetization story than the current guidance suggests is likely.

Valuation Context and Forward Scenarios

The price target cut to $14 from $17 reflects a fundamental reassessment of growth, not just a valuation haircut. The stock's forward P/E of 15.44x may not fully capture the growth slowdown implied by the guidance reset. BMO Capital's call for "further proof of ongoing AI monetization" is the core concern. The company's execution on its AI product line, which includes nearly $200 million in AI Product ARR, is solid but not yet translating into the broad, predictable revenue acceleration the market had priced in for a premium valuation.

The key operational catalysts now are execution on capital return and integration. The company has already completed a $1 billion stock repurchase program and announced a new $500 million authorization. This aggressive buyback is a direct signal of confidence in the balance sheet and a way to support the share price. Simultaneously, the successful integration of the WorkFusion acquisition is critical to expanding its AI and automation platform beyond its core RPA business. These are tangible steps, but they are operational, not growth-accelerating.

The major risk remains a slow AI monetization story. If AI-driven revenue growth fails to accelerate meaningfully, the stock will face continued multiple compression. The market is demanding a faster path to AI profitability than the current guidance suggests is likely. The bottom line is that UiPath has stabilized its growth profile and built a profitable, scalable model. But for the stock to re-rate higher, it needs to show that its AI engine is firing at full speed, providing the growth catalysts that the current valuation no longer assumes.